# Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration

> **NCT00965328** · PHASE4 · COMPLETED · sponsor: **Onze Lieve Vrouwe Gasthuis** · enrollment: 14 (actual)

## Conditions studied

- Kidney
- Acute Renal Failure
- Multiple Organ Failure

## Interventions

- **PROCEDURE:** CVVH 4 to 2 L/h
- **PROCEDURE:** CVVH 2 to 4L/h

## Key facts

- **NCT ID:** NCT00965328
- **Lead sponsor:** Onze Lieve Vrouwe Gasthuis
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2009-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965328, "Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00965328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*